HALO logo
halo search icon
Trevi Therapeutics, Inc.

US$14.16

Price Change Indicator
0.28 (2.02%)
Trevi Therapeutics, Inc.
TRVI · NAS

Trevi Therapeutics, Inc.

Start Trading TRVI for Free

US$14.16

Price Arrow0.28 (2.02%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Trevi Therapeutics, Inc. Overview

TRVI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TRVI

icon
icon

Telephone

1.203.304.2499

icon

Address

16th floor, 195 Church Street, New Haven, CT 06510

Description

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, and refractory chronic cough. The company was founded by Thomas R. Sciascia and Jennifer L. Good in 2011 and is headquartered in New Haven, CT.

TRVI Price Chart

Key Stats

Market Cap

US$1.97B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.38 - 16.12

Trade Value (12mth)

US$4,642,311.00

1 week

-2.25%

1 month

-6.22%

YTD

16.74%

1 year

130.18%

All time high

16.12

Key Fundamentals

EPS 3 yr Growth

-29.80%

EBITDA Margin

0.00%

Operating Cashflow

-$42m

Free Cash Flow Return

-29.60%

ROIC

-30.10%

Interest Coverage

0.00

Quick Ratio

19.70

Other Data

Shares Outstanding (Fully Diluted)

146m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TRVI Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
06 May 26

TRVI Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.29-0.47-0.32locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.29-0.47-0.32locklocklock
Growth
 %locklocklocklock35-60.132.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Trevi Therapeutics, Inc. (TRVI:NAS)?
Halo FAQ
The current share price of Trevi Therapeutics, Inc. (TRVI:NAS) is USD$14.16.
What is the 52-week high share price for Trevi Therapeutics, Inc. (TRVI:NAS)?
Halo FAQ
The 52-week high share price for Trevi Therapeutics, Inc. (TRVI:NAS) is USD$16.12.
What is the 52-week low share price for Trevi Therapeutics, Inc. (TRVI:NAS)?
Halo FAQ
The 52-week low share price for Trevi Therapeutics, Inc. (TRVI:NAS) is USD$5.38.
What is the dividend yield for Trevi Therapeutics, Inc. (TRVI:NAS)?
Halo FAQ
Trevi Therapeutics, Inc. (TRVI:NAS) does not pay a dividend.
What was Trevi Therapeutics, Inc. (TRVI:NAS) last dividend payment?
Halo FAQ
Trevi Therapeutics, Inc. (TRVI:NAS) does not pay a dividend.
What is the franking level for Trevi Therapeutics, Inc. (TRVI:NAS)?
Halo FAQ
Trevi Therapeutics, Inc. (TRVI:NAS) has a franking level of 0.00%.
In which sector is Trevi Therapeutics, Inc. (TRVI:NAS) classified?
Halo FAQ
Trevi Therapeutics, Inc. (TRVI:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial